Sensocure develops and manufactures biomedical sensors for healthcare, and aim to become the market leader in postoperative monitoring of internal organs.
Sensocure specializes in ischemia monitoring
The main product under development is IscAlert™, a CO2 sensor designed for the earliest possible detection of ischemia. Ischemia is a condition where the cells do not get enough oxygen to survive because of inadequate blood supply, and is the number 1 killer.
Early warning – Early action
If ischemia is detected early enough, the damage can be reversed and tissue saved. IscAlert™ detects ischemia at a very early stage by measuring the partial pressure of carbon dioxide in a body (a universal indicator of good blood supply).
Ischemia occurs in the form of myocardial infarction, stroke or
complications after operations and accidents, and is considered
the most common disease and cause of death in the
Sensocure AS develops biomedical
sensors for healthcare. The main product
under development is IscAlert™, a CO2
sensor designed for the earliest possible
detection of ischemia.
Press and public relations
Sensocure, Medistim og GE Vingmed Ultrasound har fått innvilget prosjektstøtte fra programmet BIA Helse hos Norges forskningsråd. Prosjektet er ett av tre prosjekter som har nådd frem i konkurransen om støtte, med prosjektet «Advanced Manufacturing Technologies for...
April 2017: Sensocure won a regional research grant from «Oslofjordfondet» for its Multisense project. The subject of research in this project is integration of sensors for real-time and remote measurement of vital signs, including PCO2. Such sensors have the...
Sensocure AS is a company with major ambitions in the development and delivery of sensors for medical use. New medical technology developed in the company will be a breakthrough in real-time monitoring of body functions and early detection of organ damage. Sensocure...